BACKGROUND:Blue light photodynamic therapy (PDT) is effective for actinic keratosis, but many patients experience stinging pain during illumination. OBJECTIVE: To compare a conventional regimen (1 hour of 5-aminolevulinic acid [ALA] preincubation, followed by blue light) versus a new modified regimen in which blue light is started immediately after ALA application. METHODS: A clinical trial with a bilaterally controlled, intrapatient study design was conducted with 23 patients. Topical 20% ALA was applied to the entire face and/or scalp. On 1 side of the body, blue light was started immediately and continued for either 30, 45, or 60 minutes (simultaneous PDT). On the contralateral side, the blue light began 1 hour after ALA application and lasted 1000 seconds (conventional PDT). Pain was evaluated on a scale from 0 to 10. Actinic keratosis lesion counts were determined by clinical examination and photography. RESULTS: All patients experienced significantly less pain during simultaneous illumination than during the conventional regimen. At 3 months after treatment, lesion clearance was nearly identical on the 2 sides, as determined by statistical testing of noninferiority ± 15% margin. LIMITATIONS: Although bilaterally controlled, the study was relatively small. Additional studies are recommended. CONCLUSION: The modified PDT regimen is essentially painless, yet it provides treatment efficacy similar to a conventional regimen.
RCT Entities:
BACKGROUND: Blue light photodynamic therapy (PDT) is effective for actinic keratosis, but many patients experience stinging pain during illumination. OBJECTIVE: To compare a conventional regimen (1 hour of 5-aminolevulinic acid [ALA] preincubation, followed by blue light) versus a new modified regimen in which blue light is started immediately after ALA application. METHODS: A clinical trial with a bilaterally controlled, intrapatient study design was conducted with 23 patients. Topical 20% ALA was applied to the entire face and/or scalp. On 1 side of the body, blue light was started immediately and continued for either 30, 45, or 60 minutes (simultaneous PDT). On the contralateral side, the blue light began 1 hour after ALA application and lasted 1000 seconds (conventional PDT). Pain was evaluated on a scale from 0 to 10. Actinic keratosis lesion counts were determined by clinical examination and photography. RESULTS: All patients experienced significantly less pain during simultaneous illumination than during the conventional regimen. At 3 months after treatment, lesion clearance was nearly identical on the 2 sides, as determined by statistical testing of noninferiority ± 15% margin. LIMITATIONS: Although bilaterally controlled, the study was relatively small. Additional studies are recommended. CONCLUSION: The modified PDT regimen is essentially painless, yet it provides treatment efficacy similar to a conventional regimen.
Authors: S R Wiegell; S Fabricius; I M Stender; B Berne; S Kroon; B L Andersen; C Mørk; C Sandberg; G B E Jemec; M Mogensen; K M Brocks; P A Philipsen; J Heydenreich; M Haedersdal; H C Wulf Journal: Br J Dermatol Date: 2011-04-05 Impact factor: 9.302
Authors: Lasse R Braathen; Rolf-Markus Szeimies; Nicole Basset-Seguin; Robert Bissonnette; Peter Foley; David Pariser; Rik Roelandts; Ann-Marie Wennberg; Colin A Morton Journal: J Am Acad Dermatol Date: 2007-01 Impact factor: 11.527
Authors: Ana Luiza Ribeiro de Souza; Ethan LaRochelle; Kayla Marra; Jason Gunn; Scott C Davis; Kimberley S Samkoe; M Shane Chapman; Edward V Maytin; Tayyaba Hasan; Brian W Pogue Journal: Photodiagnosis Photodyn Ther Date: 2017-10-14 Impact factor: 3.631
Authors: Edward V Maytin; Sanjay Anand; Margo Riha; Sara Lohser; Alejandra Tellez; Rim Ishak; Lauren Karpinski; Janine Sot; Bo Hu; Anton Denisyuk; Scott C Davis; Angela Kyei; Allison Vidimos Journal: Clin Cancer Res Date: 2018-03-28 Impact factor: 12.531
Authors: Daniel J Piacquadio; Diana M Chen; Harold F Farber; Joseph F Fowler; Scott D Glazer; J John Goodman; Luciann L Hruza; Edward W B Jeffes; Mark R Ling; Tania J Phillips; Tena M Rallis; Richard K Scher; Charles R Taylor; Gerald David Weinstein Journal: Arch Dermatol Date: 2004-01
Authors: Taylor A Bullock; Jeffrey Negrey; Bo Hu; Christine B Warren; Tayyaba Hasan; Edward V Maytin Journal: J Am Acad Dermatol Date: 2022-03-18 Impact factor: 15.487